PageOverview.com
 

2525 Dupont Drive registered domain names

See 54 domain name(s) that specified 2525 Dupont Drive as their possible contact address.

 
Number of websites/domains displayed: 54
Results found: 54
 

Websites discovered:

BOTOX® For Chronic Migraine | BOTOX® Chronic Migraine
http://pageoverview.com/website-report/botoxchronicmigraine.com
Learn about BOTOX® (onabotulinumtoxinA) for adults with Chronic Migraine. Read more about full safety and product information, including boxed warning.
  • Expected expiration: July 1st in 2017
  • Creation date: July 1st in 2010
  • Renew date: March 30th in 2017
  • Google Analytics: 69539686-1
ActuallySheCan
http://pageoverview.com/website-report/actuallyshecan.com
Welcome to ActuallySheCan. Come on in and see what all the fuss is about.
  • Expected expiration: March 27th in 2018
  • Creation date: March 27th in 2015
  • Renew date: March 30th in 2017
BOTOX® (OnabotulinumtoxinA) Injection and BOTOX® Cosmetic - Treatment Information
http://pageoverview.com/website-report/botox.com
Get the facts about the medical use of BOTOX® and aesthetic use of BOTOX® Cosmetic and access patient and healthcare professional portals.
  • Expected expiration: March 29th in 2021
  • Creation date: March 29th in 1999
  • Renew date: March 30th in 2017
Brilliant Distinctions® Consumer Loyalty Program
http://pageoverview.com/website-report/bdconsumerloyalty.com
  • Expected expiration: June 30th in 2018
  • Creation date: June 30th in 2009
  • Renew date: March 30th in 2017
TRELSTAR® (triptorelin pamoate for injectable suspension) | Palliative Treatment for Advanced Prostate Cancer
http://pageoverview.com/website-report/trelstar.com
TRELSTAR® (triptorelin pamoate for injectable suspension) is a palliative treatment for men with advanced prostate cancer. View Important Safety Information and full Prescribing Information on website. Learn more about Trelstar®’s MOA, efficacy, dosing, and administration.
  • Expected expiration: July 17th in 2017
  • Creation date: July 17th in 2002
  • Renew date: March 21st in 2017
SkinMedica® | Age Defying Skin Care Products Rooted in Science that Deliver Transformative Results
http://pageoverview.com/website-report/skinmedica.com
Skin care products developed to advance the science of skin rejuvenation through research, science, and innovation.
  • Expected expiration: May 28th in 2024
  • Creation date: May 28th in 1999
  • Renew date: March 30th in 2017
Home
http://pageoverview.com/website-report/mydryeyes.com
  • Expected expiration: August 20th in 2017
  • Creation date: August 20th in 2010
  • Renew date: March 8th in 2017
  • Google Analytics: 4755765-20
NAMZARIC® (memantine HCl and donepezil HCl) extended-release capsules | Official site from Allergan.
http://pageoverview.com/website-report/namzaric.com
Learn about once-a-day NAMZARIC for moderate to severe Alzheimer’s disease. See Important Risk Information for NAMZARIC.
  • Expected expiration: June 19th in 2018
  • Creation date: June 19th in 2013
  • Renew date: March 23rd in 2017
Faltenunterspritzung: Hyaluronsäure gegen Falten | Juvéderm®
http://pageoverview.com/website-report/juvederm.de
Faltenunterspritzung mit Hyaluronsäure von Juvéderm® ist eine schonende und effektive Methode gegen Falten im Gesicht. Lesen Sie mehr und finden Sie einen Facharzt.
  • Renew date: March 23rd in 2017
トータルフェイシャルトリートメントを提案する美容医療情報サイト(しわ・たるみ・ほうれい線などの改善)
http://pageoverview.com/website-report/vst-beauty.jp
しわ・たるみ・ほうれい線などを改善するためのトータルフェイシャルトリートメント、ヒアルロン酸注入治療、ボツリヌス治療の美容医療情報サイトです。
  • Expected expiration: November 30th in 2017
  • Creation date: November 26th in 2013
  • Renew date: April 5th in 2017
  • Google Analytics: 46053995-23
Savella (milnacipran HCl): Official Site
http://pageoverview.com/website-report/savella.com
Learn more about taking Savella and its potential side effects and indications. Sign up to receive a free patient brochure and additional product information as it becomes available.
  • Expected expiration: October 31st in 2018
  • Creation date: October 31st in 1999
  • Renew date: March 23rd in 2017
forestlabs.com
http://pageoverview.com/website-report/forestlabs.com
  • Expected expiration: June 30th in 2020
  • Creation date: July 1st in 1998
  • Renew date: December 23rd in 2015
Facts about Chronic Migraine | MyChronicMigraine
http://pageoverview.com/website-report/mychronicmigraine.com
If you experience Chronic Migraine, you know it's not just a headache. Learn about Chronic Migraine so you can talk with your doctor about treatment options.
  • Expected expiration: July 1st in 2018
  • Creation date: July 1st in 2010
  • Renew date: March 30th in 2017
About LINZESS | LINZESS® (linaclotide)
http://pageoverview.com/website-report/linzesshcp.com
Information for healthcare professionals on LINZESS® (linaclotide), a prescription medication that treats Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC) symptoms.
  • Expected expiration: August 28th in 2019
  • Creation date: August 28th in 2012
  • Renew date: March 23rd in 2017
OZURDEX®
http://pageoverview.com/website-report/ozurdex.com
Learn about OZURDEX® (dexamethasone intravitreal implant), a prescription medicine. Click link above for Important Safety and Product Information.
  • Expected expiration: June 10th in 2018
  • Creation date: June 10th in 2009
  • Renew date: March 23rd in 2017
Allergan - Leading Growth Pharma - Allergan
http://pageoverview.com/website-report/allergan.com
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma.
  • Expected expiration: July 13th in 2020
  • Creation date: July 14th in 1994
  • Renew date: April 14th in 2017
  • Google Analytics: 2037865-13
Low Dose Birth Control Pills | Lo Loestrin® Fe
http://pageoverview.com/website-report/loloestrin.com
Lo Loestrin Fe (norethindrone acetate & ethinyl estradiol tablets, ethinyl estradiol tablets & ferrous fumarate tablets). See Important Risk Info & Boxed Warning. Learn about Lo Loestrin Fe.
  • Expected expiration: August 12th in 2018
  • Creation date: August 12th in 2010
  • Renew date: March 23rd in 2017
LifeCell: Home
http://pageoverview.com/website-report/lifecell.com
  • Expected expiration: July 26th in 2018
  • Creation date: July 27th in 1996
  • Renew date: March 30th in 2017
  • Google Analytics: 9689002-1
Client Validation
http://pageoverview.com/website-report/juvederm.com
  • Expected expiration: May 2nd in 2021
  • Creation date: May 2nd in 2001
  • Renew date: April 14th in 2017
kurugoz.com
http://pageoverview.com/website-report/kurugoz.com
  • Expected expiration: September 15th in 2018
  • Creation date: September 15th in 2006
  • Renew date: August 14th in 2016
  • Google Analytics: 39999608-4
BOTOX® (onabotulinumtoxinA) | BOTOX® Urinary Incontinence
http://pageoverview.com/website-report/botoxforincontinence.com
Learn about BOTOX® (onabotulinumtoxinA). Click here for full safety and product information, including boxed warning. More info
  • Expected expiration: September 9th in 2017
  • Creation date: September 9th in 2011
  • Renew date: March 21st in 2017
  • Google Analytics: 31532502-1
Allergan BrandBox – Official Assets and Educational Materials
http://pageoverview.com/website-report/allerganbrandbox.com
  • Expected expiration: January 21st in 2018
  • Creation date: January 21st in 2010
  • Renew date: March 23rd in 2017
Allergan - Leading Growth Pharma - Allergan
http://pageoverview.com/website-report/aptalispharma.com
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma.
  • Expected expiration: April 11th in 2018
  • Creation date: April 11th in 2011
  • Renew date: March 30th in 2017
  • Google Analytics: 2037865-13
ArmourThyroid
http://pageoverview.com/website-report/armourthyroid.com
  • Expected expiration: October 25th in 2019
  • Creation date: October 25th in 1999
  • Renew date: March 23rd in 2017
BYSTOLIC (nebivolol) – Official Site
http://pageoverview.com/website-report/bystolic.com
Learn more about Bystolic and find information for patients, including side effects, treatment, indication, FAQs, and resources. Bystolic is a blood pressure medication that may effectively lower blood pressure when it is persistently elevated. Tell your doctor if your symptoms of heart failure worsen. Bystolic must not be taken if you have a slow heartbeat or your heart skips beats (irregular heartbeat); have severe liver damage; or are allergic to any ingredient in Bystolic. The active ingredient is nebivolol. Do not take Bystolic if you are under the age of 18 as Bystolic is not approved for use in children under 18. The most common side effects people taking Bystolic report are headache, fatigue (tiredness), dizziness (if you feel dizzy, sit or lie down and tell your doctor right away), diarrhea, nausea, insomnia (difficulty falling or staying asleep), chest pain, bradycardia (slow heartbeat), dyspnea (shortness of breath), rash, and peripheral edema (leg swelling due to fluid retention). Other possible side effects include masking (hiding) the symptoms of low blood sugar and hyperthyroidism (overactive thyroid), especially a fast heartbeat. Tell your doctor if you gain weight or have trouble breathing while taking Bystolic. This is not a complete list of side effects. Tell your doctor if you have any side effects that bother you or don’t go away.
  • Expected expiration: September 27th in 2021
  • Creation date: September 27th in 2007
  • Renew date: March 23rd in 2017
Earfold an innovative treatment - Earfold®
http://pageoverview.com/website-report/earfold.com
  • Expected expiration: May 22nd in 2019
  • Creation date: May 22nd in 2012
  • Renew date: March 13th in 2017
OTC Overactive Bladder Treatment for Women | OXYTROL® for Women
http://pageoverview.com/website-report/oxytrolforwomen.com
Do you suffer from OAB? Check out this new OTC overactive bladder treatment - OXYTROL® for Women! Find out about how it works, where to buy, and more.
  • Expected expiration: October 15th in 2020
  • Creation date: October 15th in 2012
  • Renew date: March 23rd in 2017
NAMENDA XR® | Official site from Allergan.
http://pageoverview.com/website-report/namendaxr.com
Learn about NAMENDA XR (memantine HCI) once-a-day extended release capsules for moderate to severe Alzheimer’s disease. See Important Risk Information and benefits of NAMENDA XR
  • Expected expiration: February 9th in 2021
  • Creation date: February 9th in 2009
  • Renew date: March 23rd in 2017
Eye Drops for Dry Eye Relief | Refresh Brand - Allergan
http://pageoverview.com/website-report/refreshbrand.com
Refresh offers eye drops that treat dry eye symptoms. View our eye drops and gel products.
  • Expected expiration: December 8th in 2017
  • Creation date: December 8th in 2000
  • Renew date: March 21st in 2017
Save on Treatment Costs | BOTOX® Savings Card
http://pageoverview.com/website-report/botoxsavingscard.com
Save on BOTOX® (onabotulinumtoxinA) treatment costs with the BOTOX® Savings Card. Click here for full safety and Product Information, including Boxed Warning.
  • Expected expiration: March 25th in 2018
  • Creation date: March 25th in 2014
  • Renew date: March 23rd in 2017
Brilliant Distinctions® by Allergan®
http://pageoverview.com/website-report/brilliantdistinctionsprogram.com
Brilliant Disctinctions® is the only program that rewards you with instant savings on Allergan aesthetic treatments and products, like BOTOX® Cosmetic
  • Expected expiration: June 5th in 2022
  • Creation date: June 5th in 2009
  • Renew date: March 22nd in 2017
アラガン・ジャパン - Allergan Japan - Allergan
http://pageoverview.com/website-report/allergan.jp
アラガン・ジャパンは、アイケア、神経科、皮膚科、美容医療、形成外科、乳腺外科、泌尿器科、消化器科、婦人科など多岐に渡る領域で有力製品を抱えるグローバルヘルスケア・カンパニーの日本法人です。
  • Expected expiration: May 31st in 2017
  • Creation date: May 15th in 2001
  • Renew date: April 4th in 2017
  • Google Analytics: 74593941-22
Overactive Bladder Treatment Option | BOTOX® for OAB
http://pageoverview.com/website-report/botoxforoab.com
Learn about BOTOX® (onabotulinumtoxinA) for adults with Overactive Bladder. Click here for full safety and product information, including boxed warning.
  • Expected expiration: August 22nd in 2018
  • Creation date: August 22nd in 2012
  • Renew date: March 23rd in 2017
Allergan|One
http://pageoverview.com/website-report/allerganone.com
  • Expected expiration: June 9th in 2018
  • Creation date: June 9th in 2014
  • Renew date: March 23rd in 2017
Allergan - Leading Growth Pharma - Allergan
http://pageoverview.com/website-report/frx.com
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma.
  • Expected expiration: April 5th in 2022
  • Creation date: April 4th in 1994
  • Renew date: March 30th in 2017
  • Google Analytics: 2037865-13
The only prescription treatment for inadequate or not enough eyelashes | LATISSE® (bimatoprost ophthalmic solution) 0.03%
http://pageoverview.com/website-report/latisse.com
LATISSE® (bimatoprost ophthalmic solution) 0.03% — the first and only FDA-approved treatment for inadequate or not enough lashes.
  • Expected expiration: August 13th in 2020
  • Creation date: August 13th in 2003
  • Renew date: March 30th in 2017
SkinMedica®: Skin Care Products
http://pageoverview.com/website-report/skinmedica.hk
Our clinical aesthetic skin care line is based on the science of the skin's own healing abilities to regenerate the health of the skin and counteract the effects of aging
  • Expected expiration: March 30th in 2019
  • Google Analytics: 5035875-1
Pacific Communications
http://pageoverview.com/website-report/pacific-com.com
  • Expected expiration: August 9th in 2017
  • Creation date: August 10th in 1996
  • Renew date: July 8th in 2015
  • Google Analytics: 78290422-1
The First & Only Injectable Double Chin Treatment | KYBELLA®
http://pageoverview.com/website-report/mykybella.com
Discover KYBELLA® (deoxycholic acid), the first and only FDA-approved injectable treatment to reduce fat under the chin.
  • Expected expiration: May 15th in 2019
  • Creation date: May 15th in 2014
  • Renew date: April 14th in 2017
RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%: Prescription Eye Drops for Chronic Dry Eye Patients – RESTASIS Rebate – Find an Eye Doctor
http://pageoverview.com/website-report/restasis.com
Learn about RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% prescription eye drops for increasing tear production in patients with a type of Chronic Dry Eye disease.
  • Expected expiration: December 22nd in 2017
  • Creation date: December 22nd in 1998
  • Renew date: March 30th in 2017
Choose FETZIMA® (levomilnacipran) ER Capsules to Treat MDD
http://pageoverview.com/website-report/fetzima.com
FETZIMA® is FDA approved for the treatment of Major Depressive Disorder in adults. See risk info, including Boxed Warning & full Prescribing Information.
  • Expected expiration: February 28th in 2019
  • Creation date: February 29th in 2012
  • Renew date: March 23rd in 2017
Earfold eine innovative Behandlung - Earfold®
http://pageoverview.com/website-report/allergan-earfold.de
Earfold<sup class='reg-mark'>®</sup> ist ein minimalinvasiver Eingriff für abstehende Ohren mit kurzer Erholungszeit. Earfold<sup class='reg-mark'>®</sup> ist für Erwachsene und Kinder ab dem Alter von sieben Jahren geeignet.
  • Renew date: July 13th in 2017
India - Leading Growth Pharma - Allergan
http://pageoverview.com/website-report/allergan.co.in
Allergan India. Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma.
  • Expected expiration: March 31st in 2018
  • Creation date: March 31st in 2003
  • Renew date: January 5th in 2017
  • Google Analytics: 74593941-8
ZENPEP® (pancrelipase) Delayed Release Capsules Official Site from Allergan®
http://pageoverview.com/website-report/zenpep.com
ZENPEP is a prescription medicine for people who cannot digest food normally because their pancreas does not make enough enzymes. See Important Risk Information for ZENPEP. Learn about dosing, risks, and side effects.
  • Expected expiration: May 15th in 2021
  • Creation date: May 15th in 2008
  • Renew date: March 23rd in 2017
BOTOX® (onabotulinumtoxinA) for Medical Professionals
http://pageoverview.com/website-report/botoxmedical.com
Access exclusive BOTOX® training resources and learn about BOTOX® indications. See full safety and Prescribing Information including Boxed Warning.
  • Expected expiration: September 30th in 2020
  • Creation date: September 30th in 2005
  • Renew date: January 8th in 2015
VIBERZI (eluxadoline) CIV | Official Site
http://pageoverview.com/website-report/viberzi.com
See info on VIBERZI (eluxadoline) for the treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in adult patients. See Important Risk Information for VIBERZI.
  • Expected expiration: February 9th in 2019
  • Creation date: February 9th in 2015
  • Renew date: March 30th in 2017
  • AddThis User: ra-58ff8f98203f664c
ACZONE® (dapsone) Gel 7.5% | Prescription Acne Medication
http://pageoverview.com/website-report/aczone.com
ACZONE® Gel is a prescription medicine used on the skin (topical) to treat acne in people 12 years and older. View important safety information.
  • Expected expiration: May 31st in 2022
  • Creation date: June 1st in 1998
  • Renew date: March 30th in 2017
BOTOX® for Severe Underarm Sweating - Botox
http://pageoverview.com/website-report/botoxseveresweating.com
  • Expected expiration: July 1st in 2021
  • Creation date: July 1st in 2004
  • Renew date: March 23rd in 2017
BOTOX® Cosmetic (onabotulinumtoxinA) official site. Welcome!
http://pageoverview.com/website-report/botoxcosmetic.com
Learn about BOTOX® Cosmetic for moderate to severe frown lines and crow's feet. Click here for full safety and product information, including boxed warning.
  • Expected expiration: August 26th in 2020
  • Creation date: August 26th in 2001
  • Renew date: March 30th in 2017
VIIBRYD® (vilazodone HCl) For Major Depressive Disorder
http://pageoverview.com/website-report/viibryd.com
Learn about VIIBRYD®, and how it may help you manage your condition. See risk info, including Boxed Warning & full Prescribing Information.
  • Expected expiration: August 12th in 2018
  • Creation date: August 12th in 2010
  • Renew date: March 23rd in 2017
Savings Card Activation - Savella Registration
http://pageoverview.com/website-report/savingscardactivation.com
  • Expected expiration: March 17th in 2018
  • Creation date: March 17th in 2016
  • Renew date: March 30th in 2017
Allergan Partner Privileges®
http://pageoverview.com/website-report/allergannetwork.com
  • Expected expiration: October 2nd in 2020
  • Creation date: October 2nd in 2007
  • Renew date: March 30th in 2017
Live2Thrive®: Cystic Fibrosis Patient Support Program Brought to You by Allergan
http://pageoverview.com/website-report/live2thrive.org
Save Money, Earn Points. Get Rewards. The LIVE2THRIVE Program offers all this and more for eligible patients with cystic fibrosis (CF). As a LIVE2THRIVE member, you will be able to receive free vitamins & supplements, copay assistance, and loyalty rewards. This program also provides diet and nutrition information, including high-calorie recipes, and offers tips for managing CF in everyday life.
  • Expected expiration: October 21st in 2019
  • Creation date: October 21st in 2011
  • Renew date: March 30th in 2017
Registered & Protected by MarkMonitor
http://pageoverview.com/website-report/juvederm.co.za
  • Expected expiration: September 17th in 2018
  • Creation date: September 17th in 2012
  • Renew date: August 16th in 2017
0.0533 // 2024-05-02 06:35:24
All Rights reserved 2018 © PageOverview.com